Patient baseline characteristics at the initiation of teclistamab
| Characteristics . | Frequency . |
|---|---|
| Age at diagnosis, y, median (min-max) | 64 (41-78) |
| Age at teclistamab therapy, y, median (min-max) | 66 (43-81) |
| Sex, n (%) | |
| Male | 8 (50) |
| Female | 8 (50) |
| Race, n (%) | |
| White | 13 (81.25) |
| Black | 3 (18.75) |
| Myeloma subtype, n (%) | |
| IgG | 9 (56.25) |
| IgA | 3 (18.75) |
| IgM | 1 (6.25) |
| Light chain | 3 (18.75) |
| High-risk cytogenetics, n (%) | 16 (100) |
| Triple-refractory∗, n (%) | 15 (93.75) |
| Penta-refractory†, n (%) | 10 (62.5) |
| Number of prior lines of therapy, median (range) | 4.5 (2-10) |
| Prior BCMA-targeted therapy, n (%) | 4 (25) |
| Number of prior stem cell transplants, n (%) | |
| 0 | 2 (12.5) |
| 1 | 10 (62.5) |
| 2 | 4 (25) |
| PET scan ≥3 focal lesions, n (%) | 8 (50) |
| EMD, n (%) | 5 (31.25) |
| CPCs, %, median (range) | 7.45 (5-82) |
| Serum creatinine (mg/dL), median (range) | 1.1 (0.6-7.0) |
| Hemoglobin (g/dL), median (range) | 8.6 (6.7-10.7) |
| Absolute neutrophil count (× 103/μL), median (range) | 1.5 (0.1-7.4) |
| ALC (× 103/μL), median (range) | 0.5 (0.2-6.5) |
| Platelet count (× 103/μL), median (range) | 28 (3-170) |
| Characteristics . | Frequency . |
|---|---|
| Age at diagnosis, y, median (min-max) | 64 (41-78) |
| Age at teclistamab therapy, y, median (min-max) | 66 (43-81) |
| Sex, n (%) | |
| Male | 8 (50) |
| Female | 8 (50) |
| Race, n (%) | |
| White | 13 (81.25) |
| Black | 3 (18.75) |
| Myeloma subtype, n (%) | |
| IgG | 9 (56.25) |
| IgA | 3 (18.75) |
| IgM | 1 (6.25) |
| Light chain | 3 (18.75) |
| High-risk cytogenetics, n (%) | 16 (100) |
| Triple-refractory∗, n (%) | 15 (93.75) |
| Penta-refractory†, n (%) | 10 (62.5) |
| Number of prior lines of therapy, median (range) | 4.5 (2-10) |
| Prior BCMA-targeted therapy, n (%) | 4 (25) |
| Number of prior stem cell transplants, n (%) | |
| 0 | 2 (12.5) |
| 1 | 10 (62.5) |
| 2 | 4 (25) |
| PET scan ≥3 focal lesions, n (%) | 8 (50) |
| EMD, n (%) | 5 (31.25) |
| CPCs, %, median (range) | 7.45 (5-82) |
| Serum creatinine (mg/dL), median (range) | 1.1 (0.6-7.0) |
| Hemoglobin (g/dL), median (range) | 8.6 (6.7-10.7) |
| Absolute neutrophil count (× 103/μL), median (range) | 1.5 (0.1-7.4) |
| ALC (× 103/μL), median (range) | 0.5 (0.2-6.5) |
| Platelet count (× 103/μL), median (range) | 28 (3-170) |